Techniques and Strategies in Drug Design and Discovery

George Mihai Nitulescu
DOI: https://doi.org/10.3390/ijms25031364
IF: 5.6
2024-01-24
International Journal of Molecular Sciences
Abstract:The process of drug discovery constitutes a highly intricate and formidable undertaking, encompassing the identification and advancement of novel therapeutic entities [...]
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to explore various techniques and strategies in the field of drug design and discovery. Specifically, the paper showcases several key methods in current drug design through different research cases: 1. **Scaffold-based design approach**: This involves designing new compounds by identifying scaffold structures with specific biological activities. For example, Tamanova et al. used this strategy to develop novel 2,7,9-trisubstituted 8-oxopurines as FLT3 inhibitors and analyzed their role in the treatment of acute myeloid leukemia. 2. **Target-based approach**: The review by Mercurio et al. discusses how to develop anticancer peptide drugs by inhibiting specific protein-protein interactions, particularly targeting the SAM domain of the EphA2 receptor (EphA2-SAM). 3. **Deep learning approach**: Lu Wang et al. proposed a new model named AMMVF-DTI, which utilizes self-attention mechanisms and multi-view fusion techniques to predict drug-target interactions (DTI). This method can more effectively assess the interactions between drugs and target proteins. 4. **Sequence-based approach**: Ghemire et al. introduced a model named CSatDTA for predicting drug-target affinity (DTA). This model combines convolutional self-attention mechanisms to better capture long-range interactions. Overall, this paper aims to showcase the latest advancements in different drug design strategies, emphasizing the importance of innovation and improvement for more effective drug development.